Universita' Degli Studi Di Milano Dna

Universita' Degli Studi Di Milano Dna

UNIVERSITA’ DEGLI STUDI DI MILANO Scuola di Dottorato in Scienze Biomediche Cliniche e Sperimentali Corso di Dottorato in Biotecnologie Applicate alle Scienze Mediche Ciclo XXIV Tesi di dottorato di ricerca DNA METHYLATION AS A PREDISPOSITION FACTOR IN THE PATHOGENESIS OF CONGENITAL HYPOTHYROIDISM IN PRETERM INFANTS Facoltà di Medicina e Chirurgia Settore Scientifico Disciplinare Bio13 Coordinatore: Prof. Enrico GINELLI Tutor: Prof. Luca PERSANI Dottorando: Federica MARELLI Matricola n. R08135 Anno Accademico 2011-2012 Table of contests TABLE OF CONTESTS ................................................................................................................... 2 ABSTRACT ................................................................................................................................... 5 INTRODUCTION-CHAPTER I ......................................................................................................... 7 1. THYROID GLAND DEVELOPMENT AND DEFECTS ...................................................................... 7 1.1 FETAL THYROID DEVELOPMENT: A BRIEF OVERVIEW ............................................................ 7 1.1.1 MORPHOLOGICAL ASPECTS ................................................................................................ 7 1.1.2 GENETIC COMPONENT ON THYROID DEVELOPMENT ....................................................... 10 1.2 THYROID HORMONE METABOLISM AND ACTION ............................................................... 11 1.3 CONGENITAL HYPOTHYROIDISM ......................................................................................... 15 1.3.1 THYROID DYSGENESIS ...................................................................................................... 15 1.3.2 DYSORMONOGENESIS ...................................................................................................... 17 1.3.3 INCIDENCES OF CONGENITAL HYPOTHYROIDISM ............................................................. 18 INTRODUCTION-CHAPTER II ...................................................................................................... 22 2. EPIGENETIC MECHANISMS .................................................................................................... 22 2.1 A BRIEF OVERVIEW ............................................................................................................. 22 2.2 EPIGENETIC COMPONENTS ................................................................................................. 23 2.2.1 HISTONES MODIFICATIONS .............................................................................................. 23 2.2.2 MICRORNAS ..................................................................................................................... 24 2.3 THE DNA METHYLATION ..................................................................................................... 26 2.3.1 INTRODUCTION OF DNA METHYLATION........................................................................... 26 2.3.2 5′-METHYLCYTOSINE AND THE CPG DINUCLEOTIDE .......................................................... 28 2.3.3 GENOMIC DISTRIBUTION OF 5′-METHYLCYTOSINE ........................................................... 31 2.3.4 CPG SITES HELP DETERMINE GENE EXPRESSION STATE .................................................... 34 2.4 ROLES OF DNA METHYLATION ............................................................................................ 35 2.4.1 TRANSPOSON SUPPRESSION-DNA METHYLATION AS A GENETIC DEFENSE ...................... 35 2.4.2 DNA METHYLATION AND DEVELOPMENT ........................................................................ 36 2.4.3 X CHROMOSOME INACTIVATION ..................................................................................... 38 2.4.4 IMPRINTING ..................................................................................................................... 39 INTRODUCTION-CHAPTER III ..................................................................................................... 41 3. DNA METHYLATION AND HUMAN DISEASES ......................................................................... 41 3.1 EPIGENETIC DYSREGULATION IN HUMAN DISEASES ............................................................ 41 3.1.1 DNA METHYLATION AND CANCER .................................................................................... 41 2 3.1.2 DNA METHYLATION AND REPRODUCTION ....................................................................... 42 3.1.3 DNA METHYLATION AND CARDIOVASCULAR DISEASE ...................................................... 43 3.1.4 DNA METHYLATION AND TYPE 2 DIABETES ...................................................................... 44 3.1.5 DNA METHYLATION AND OBESITY .................................................................................... 45 3.2. DEVELOPMENTAL ORIGIN OF HEALTH AND DISEASE HYPOTHESIS (DOHAD) ...................... 46 3.2.1 FETAL PROGRAMMING ..................................................................................................... 46 3.2.2 RETROSPECTIVE STUDIES .................................................................................................. 50 3.2.3 EXPERIMENTAL STUDIES ................................................................................................... 51 CHAPTER IV ............................................................................................................................... 53 4. AIMS OF PHD PROJECT .......................................................................................................... 54 CHAPTER V ................................................................................................................................ 55 5. MATERIALS AND METHODS ................................................................................................... 55 5.1 SAMPLES COLLECTION AND DNA EXTRACTION .................................................................... 56 5.1.1 RECRUITMENT OF PATIENTS ............................................................................................. 56 5.1.2 DNA ISOLATION FROM PERIPHERAL BLOOD SAMPLES ..................................................... 56 5.1.3 DNA QUALITY AND QUANTITY .......................................................................................... 58 5.2 DNA METHYLATION ANALYSIS............................................................................................. 59 5.2.1 DNA BISULFITE TREATMENT ............................................................................................. 59 5.2.2 INFINIUM ASSAY FOR METHYLATION ............................................................................... 60 5.3 ANALYSIS OF DNA METHYLATION DATA .............................................................................. 63 5.3.1 EXPERIMENTAL DESIGN AND QUALITY CONTROL ............................................................. 63 5.3.2 PRINCIPAL COMPONENT ANALYSIS .................................................................................. 64 5.3.3 DETERMINATION OF DIFFERENTIALLY METHYLATED CPG SITES........................................ 64 5.4 BIOLOGICAL PROCESSES AND PATHWAY ANALYSIS ............................................................. 66 5.4.1 FUNCTIONAL ANNOTATION OF GENE LISTS ...................................................................... 66 5.4.2 INDIVIDUAL GENE INFORMATION .................................................................................... 66 5.5 ANALYSIS OF MTHFR POLYMORPHISMS .............................................................................. 67 CHAPTER VI ............................................................................................................................... 68 6. RESULTS ................................................................................................................................ 68 6.1 DESIGN OF DNA METHYLATION STUDY ............................................................................... 68 6.1.1 STATISTICAL METHODS .................................................................................................... 68 6.1.2 COLLECTIONS OF CH AND CONTROL SUBJECTS ................................................................. 69 6.1.3 DESIGN OF DNA METHYLATION STUDIES .......................................................................... 71 6.1.4 CATEGORIZATION OF SUBJECTS ACCORDING TO THEIR CLINICAL DATA ........................... 74 3 6.2 ANOVA STATISTICAL ANALYSIS ........................................................................................... 78 6.3 CLUSTERING OF SUBJECTS ................................................................................................... 80 6.4 GLOBAL DNA METHYLATION ANALYSIS ............................................................................... 82 6.4.1 REPRESENTATION OF DNA METHYLATION TRENDS .......................................................... 82 6.4.2 COMPARISON OF MEAN-AVGBETA VALUES ..................................................................... 84 6.4.3 SUMMARY OF GLOBAL METHYLATION ANALYSIS RESULTS .............................................. 87 6.5 GENE-SPECIFIC DNA METHYLATION ANALYSIS .................................................................... 88 6.5.1 SELECTION OF DIFFERENTIALLY METHYLATED GENES (DMGS) ......................................... 88 6.5.2 SELECTION OF “COMMON GENES” ................................................................................... 90 6.5.3

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    145 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us